Suzhou Mednovo Yi Medical Technology Co., Ltd.
1 clinical trials · Sponsor
◉ Watch Suzhou Mednovo Yi Medical Technology Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| MDN-001 Injection for the Treatment of Unresectable Primary Hepatocellular Carcinoma. (NCT07391839) | Suzhou Mednovo Yi Medical Technology Co., Ltd. | 2025-08-04 |
Track Suzhou Mednovo Yi Medical Technology Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.